Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02370160
Recruitment Status : Completed
First Posted : February 24, 2015
Last Update Posted : September 27, 2018
Sponsor:
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 8, 2018
  Actual Study Completion Date : March 8, 2018